| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 767 | 2015 |
| Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. G Sanna, ML Bertolaccini, MJ Cuadrado, H Laing, MA Khamashta, ... The Journal of rheumatology 30 (5), 985-992, 2003 | 614 | 2003 |
| Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open … H Cohen, BJ Hunt, M Efthymiou, DRJ Arachchillage, IJ Mackie, ... The Lancet Haematology 3 (9), e426-e436, 2016 | 405 | 2016 |
| Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients R Cervera, MA Khamashta, Y Shoenfeld, MT Camps, S Jacobsen, E Kiss, ... Annals of the Rheumatic Diseases 68 (9), 1428-1432, 2009 | 393 | 2009 |
| Association of autoantibodies against the phosphatidylserine–prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant T Atsumi, M Ieko, ML Bertolaccini, K Ichikawa, A Tsutsumi, E Matsuura, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 369 | 2000 |
| The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 346 | 1998 |
| GAPSS: the global anti-phospholipid syndrome score S Sciascia, G Sanna, V Murru, D Roccatello, MA Khamashta, ... Rheumatology 52 (8), 1397-1403, 2013 | 344 | 2013 |
| Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus N Marto, ML Bertolaccini, E Calabuig, GRV Hughes, MA Khamashta Annals of the rheumatic diseases 64 (3), 444-448, 2005 | 286 | 2005 |
| 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends ML Bertolaccini, O Amengual, L Andreoli, T Atsumi, CB Chighizola, ... Autoimmunity reviews 13 (9), 917-930, 2014 | 270 | 2014 |
| Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome S Sciascia, G Sanna, V Murru, D Roccatello, MA Khamashta, ... Thrombosis and haemostasis 112 (02), 354-364, 2014 | 267 | 2014 |
| Circulating oxidized LDL forms complexes with β2-glycoprotein I: implication as an atherogenic autoantigen K Kobayashi, M Kishi, T Atsumi, ML Bertolaccini, H Makino, N Sakairi, ... Journal of lipid research 44 (4), 716-726, 2003 | 267 | 2003 |
| Central nervous system involvement in the antiphospholipid (Hughes) syndrome G Sanna, ML Bertolaccini, MJ Cuadrado, MA Khamashta, GRV Hughes Rheumatology 42 (2), 200-213, 2003 | 234 | 2003 |
| ‘Non-criteria’aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010 ML Bertolaccini, O Amengual, T Atsumi, WL Binder, B Laat, R Forastiero, ... Lupus 20 (2), 191-205, 2011 | 186 | 2011 |
| The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review S Sciascia, G Sanna, MA Khamashta, MJ Cuadrado, D Erkan, L Andreoli, ... Annals of the rheumatic diseases 74 (11), 2028-2033, 2015 | 175 | 2015 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 150 | 2023 |
| Features associated with epilepsy in the antiphospholipid syndrome. Y Shoenfeld, S Lev, I Blatt, M Blank, J Font, P von Landenberg, N Lev, ... The Journal of Rheumatology 31 (7), 1344-1348, 2004 | 148 | 2004 |
| Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called ‘seronegative APS’) JL Rodriguez-Garcia, ML Bertolaccini, MJ Cuadrado, G Sanna, ... Annals of the rheumatic diseases 71 (2), 242-244, 2012 | 141 | 2012 |
| Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities S Sciascia, V Murru, G Sanna, D Roccatello, MA Khamashta, ... Journal of Thrombosis and Haemostasis 10 (12), 2512-2518, 2012 | 134 | 2012 |
| Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review S Sciascia, ML Bertolaccini, D Roccatello, MA Khamashta, G Sanna Journal of neurology 261, 1706-1714, 2014 | 132 | 2014 |
| Antiprothrombin antibodies detected in two different assay systems ML Bertolaccini, T Atsumi, T Koike, GRV Hughes, MA Khamashta Thrombosis and haemostasis 93 (02), 289-297, 2005 | 132 | 2005 |
